Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer turns to upstart CytomX for $635M deal on armed antibody tech
Fierce Pharma
Thursday, June 6, 2013 - 11:51am
tags:
CytomX, Pfizer, antibody-drug conjugate
Generic Threats To Amgen's Biologics
Seeking Alpha
Thursday, June 6, 2013 - 11:49am
tags:
Amgen, generics, biosimilars, Neupogen, Aranesp, Epogen
Old-School Pharma/Biotech Dividend Paying Comparison
Seeking Alpha
Thursday, June 6, 2013 - 11:46am
tags:
dividends, Amgen, Bristol-Myers Squibb, Merck, Hisun-Pfizer Pharmaceuticals
Regeneron, Bayer reports positive Phase 3 results for Eylea
Yahoo/Fly on the Wall
Thursday, June 6, 2013 - 10:55am
tags:
Bayer, Eylea, Regeneron, myopic choroidal neovascularization
Royalty Pharma Extends $6.4B Takeover Over for Elan
Bloomberg
Thursday, June 6, 2013 - 10:53am
tags:
Elan, Royalty Pharma, M&A
Vivus Fighting 3 Front War
Seeking Alpha
Thursday, June 6, 2013 - 10:53am
tags:
Vivus, obesity, Arena Pharmaceuticals, Qsymia, Belviq
U.S. FDA panel revisits Avandia, likely too late for diabetes drug
Reuters
Thursday, June 6, 2013 - 10:47am
tags:
advisory panels, FDA, diabetes, GSK, Avandia
Sky-high drug prices will force change in cancer care, experts say
Fierce Pharma
Thursday, June 6, 2013 - 10:45am
tags:
cancer, drug pricing
Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca
Yahoo
Thursday, June 6, 2013 - 10:36am
tags:
Isis Pharmaceuticals, AstraZeneca
Aveo's Future Depends on Triple-Negative Breast Cancer
TheStreet.com
Thursday, June 6, 2013 - 10:35am
tags:
Aveo Oncology, triple-negative breast cancer, tivozanib
Remember Vertex? Important Cystic Fibrosis Data On Tap Next Week
TheStreet.com
Thursday, June 6, 2013 - 10:08am
tags:
Vertex Pharmaceuticals, cystic fibrosis, Kalydeco, VX-661
Bristol-Myers Squibb: The Untold Story Of Led Zeppelin
Seeking Alpha
Thursday, June 6, 2013 - 10:07am
tags:
Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, Forest Labs
Novo Nordisk Has One of the Widest Moats in Health Care
Yahoo/Morningstar
Thursday, June 6, 2013 - 10:04am
tags:
Novo Nordisk, diabetes
Celgene's Revlimid wins additional FDA lymphoma approval
Reuters
Wednesday, June 5, 2013 - 5:35pm
tags:
Celgene, Revlimid, FDA, lymphoma, mantle cell lymphoma
Meda AB denies acquisition talks with Sun Pharma
Economic Times, India
Wednesday, June 5, 2013 - 5:33pm
tags:
Sun Pharma, M&A, India, Meda AB
Endo Health to cut 15 pct jobs, explore options for two units
Reuters
Wednesday, June 5, 2013 - 5:32pm
tags:
Endo Health Solutions, layoffs
FDA Avandia Panel: A Twitter-Based Review
Forbes
Wednesday, June 5, 2013 - 5:31pm
tags:
twitter, social media, GSK, FDA, advisory panels, Avandia, diabetes
Does Pfizer's Unwinding of Its Stake in Zoetis Offer Value for Either Company's Shareholders?
Motley Fool
Wednesday, June 5, 2013 - 5:29pm
tags:
Zoetis, animal health, Pfizer
Drug companies look to profit from DSM-5
Marketwatch
Wednesday, June 5, 2013 - 12:43pm
tags:
mental illness, DSM-5
pSivida Drug Technology And Pipeline Make It One Of The Most Undervalued Biotechs For 2013
Seeking Alpha
Wednesday, June 5, 2013 - 12:30pm
tags:
pSivida, Pfizer, Retisert, Vitrasert, Tethadur, Durasert, Latanaprost

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.